| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | +3.4% | -3.4% |
| Cost of Revenue | $1.1M | -9.8% | -28.0% |
| R&D Expense | $679K | -7.1% | -9.4% |
| SG&A Expense | $1.9M | -10.6% | -40.8% |
| Operating Income | -$1.5M | +25.6% | +54.5% |
| Interest Expense | $76K | +9.6% | -57.8% |
| Pre-tax Income | -$721K | +9.2% | +90.9% |
| Net Income | -$721K | +9.2% | +90.9% |
| EPS (Basic) | -$0.06 | +14.3% | +98.3% |
| EPS (Diluted) | -$0.06 | +14.3% | +98.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $208K | +22.9% | -95.3% |
| Accounts Receivable | $52K | -44.5% | -46.1% |
| Current Assets | $910K | -20.3% | -84.9% |
| Total Assets | $2.8M | -11.0% | -70.9% |
| Current Liabilities | $29.2M | -1.8% | -37.6% |
| Long-term Debt | $2.3M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | — |
| Capital Expenditures | $4K | — | — |
| Investing Cash Flow | -$4K | — | — |
| Financing Cash Flow | $379K | — | — |
| Free Cash Flow | -$1.3M | — | — |
| -24.0% |
| Total Liabilities | $30.2M | -2.0% | -37.0% |
| Stockholders' Equity | -$27.4M | +1.0% | +28.6% |